Teva Pharmaceutical Industries Limited (TEVA)

Teva Pharmaceutical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	713	-1,639	-559	-2,446	417	-3,990
Depreciation & Amortization	1,011	1,059	1,153	1,308	1,330	1,557
Loss (Gain) From Sale of Assets	-	-22	-41	10	-	-
Asset Writedown & Restructuring Costs	1,052	2,555	1,078	2,447	594	6,626
Loss (Gain) From Sale of Investments	-	-	-	-	104	-213
Stock-Based Compensation	140	123	121	124	119	129
Other Operating Activities	-10	-394	-312	-1,208	-65	-705
Change in Accounts Receivable	245	245	12	334	-574	-293
Change in Inventory	166	166	-147	-163	380	41
Change in Accounts Payable	258	258	1,588	2,012	764	-463
Change in Other Net Operating Assets	-2,509	-1,104	-1,525	-828	-2,271	-1,473
Operating Cash Flow	1,066	1,247	1,368	1,590	798	1,216
Operating Cash Flow Growth	-42.56%	-8.85%	-13.96%	99.25%	-34.38%	62.57%
Capital Expenditures	-488	-498	-526	-548	-562	-578
Cash Acquisitions	-	-15	-	-7	-	-
Divestitures	38	43	68	68	311	67
Investment in Securities	-55	-31	-46	3	125	-43
Other Investing Activities	7	2	-5	-	1	12
Investing Cash Flow	774	792	968	656	1,523	863
Short-Term Debt Issued	-	-	700	-	700	550
Long-Term Debt Issued	-	-	2,451	-	4,974	-
Total Debt Issued	2,298	-	3,151	-	5,674	550
Short-Term Debt Repaid	-	-	-700	-	-700	-559
Long-Term Debt Repaid	-	-1,641	-4,152	-1,369	-7,140	-1,871
Total Debt Repaid	-4,797	-1,641	-4,852	-1,369	-7,840	-2,430
Net Debt Issued (Repaid)	-2,499	-1,641	-1,701	-1,369	-2,166	-1,880
Other Financing Activities	-366	-150	-212	-118	-6	-5
Financing Cash Flow	-2,865	-1,791	-1,913	-1,487	-2,172	-1,885
Foreign Exchange Rate Adjustments	-90	-174	-30	-123	-128	8
Miscellaneous Cash Flow Adjustments	-1	-1	-	-	-	-
Net Cash Flow	-1,116	73	393	636	21	202
Free Cash Flow	578	749	842	1,042	236	638
Free Cash Flow Growth	-57.75%	-11.04%	-19.19%	341.52%	-63.01%	186.10%
Free Cash Flow Margin	3.45%	4.53%	5.31%	6.98%	1.49%	3.83%
Free Cash Flow Per Share	0.50	0.66	0.75	0.94	0.21	0.58
Cash Interest Paid	1,004	1,004	1,078	948	913	846
Cash Income Tax Paid	471	471	298	543	495	709
Levered Free Cash Flow	1,003	2,622	3,294	2,900	2,307	1,764
Unlevered Free Cash Flow	1,600	3,249	3,938	3,481	2,863	2,327
Change in Working Capital	-1,840	-435	-72	1,355	-1,701	-2,188

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q